(HONOLULU, HAWAII, OCTOBER 24, 2011) — Sildenafil is currently approved for adult pulmonary arterial hypertension (PAH) but new research presented at CHEST 2011 shows the drug may also provide significant benefits for children with PAH, helping to improve both oxygen delivery and exercise capacity.
PAH, characterized by narrowing of the small arteries that carry blood from the heart to the lungs, leads to shortness of breath, chest pain, swelling in the lower body, fatigue, and heart failure.